As of May 26
| +0.37 / +1.28%|
The 1 analysts offering 12-month price forecasts for Taro Pharmaceutical Industries Ltd have a median target of 35.00, with a high estimate of 35.00 and a low estimate of 35.00. The median estimate represents a +19.29% increase from the last price of 29.34.
The current consensus among 1 polled investment analysts is to Buy stock in Taro Pharmaceutical Industries Ltd. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.